Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management

References

• LeclercqRDerlotEDuvalJCourvalinPPlasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faeciumN Engl J Med198831931571612968517
   PubMed Web of Science ®Google Scholar
• UttleyAHCollinsCHNaidooJGeorgeRCVancomycin-resistant enterococciLancet198818575–657582891921
   PubMed Web of Science ®Google Scholar
• SahmDFKissingerJGilmoreMSIn vitro susceptibility studies of vancomycin-resistant Enterococcus faecalisAntimicrob Agents Chemother1989339158815912554802
   PubMed Web of Science ®Google Scholar
• AcarJCasewellMFreemanJFriisCGoossensHAvoparcin and virginiamycin as animal growth promoters: a plea for science in decision-makingClin Microbiol Infect20006947748211168181
   PubMed Web of Science ®Google Scholar
• KirstHAThompsonDGNicasTIHistorical yearly usage of vancomycinAntimicrob Agents Chemother1998425130313049593175
   PubMed Web of Science ®Google Scholar
• BontenMJWillemsRWeinsteinRAVancomycin-resistant enterococci: why are they here, and where do they come from?Lancet Infect Dis20011531432511871804
   PubMedGoogle Scholar
• FriedenTRMunsiffSSLowDEEmergence of vancomycin- resistant enterococci in New York CityLancet1993342886376798100912
   PubMed Web of Science ®Google Scholar
• The European Antimicrobial Resistance Surveillance SystemEARS-Net Results2015 Available from: http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspxAccessed January 1, 2015
   Google Scholar
• ChangSSievertDMHagemanJCInfection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance geneN Engl J Med2003348141342134712672861
   PubMed Web of Science ®Google Scholar
• EuzébyJPList of Prokaryotic Names with Standing in Nomenclature – Genus Enterococcus2015 Available from: http://www.bacterio.net/enterococcus.htmlAccessed February 17, 2015
   Google Scholar
• SievertDMRicksPEdwardsJRNational Healthcare Safety Network (NHSN)Team and Participating NHSN Facilities Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention 2009–2010Infect Control Hosp Epidemiol201334111423221186
   PubMed Web of Science ®Google Scholar
• FrenchGLEnterococci and vancomycin resistanceClin Infect Dis199827Suppl 1S75S839710674
   PubMed Web of Science ®Google Scholar
• ZirakzadehAPatelRVancomycin-resistant enterococci: colonization, infection, detection, and treatmentMayo Clin Proc200681452953616610573
   PubMed Web of Science ®Google Scholar
• CattoirVLeclercqRTwenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?J Antimicrob Chemother201368473174223208830
   PubMed Web of Science ®Google Scholar
• MoelleringRCJrThe Garrod lecture. The Enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic optionsJ Antimicrob Chemother19912811121769929
   PubMed Web of Science ®Google Scholar
• MurrayBEVancomycin-resistant enterococciAm J Med199710232842939217598
   PubMed Web of Science ®Google Scholar
• MoelleringRCJrWeinbergANStudies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococciJ Clin Invest19715012258025845001959
   PubMed Web of Science ®Google Scholar
• AriasCAContrerasGAMurrayBEManagement of multidrug-resistant enterococcal infectionsClin Microbiol Infect201016655556220569266
   PubMed Web of Science ®Google Scholar
• RybkineTMainardiJLSougakoffWCollatzEGutmannLPenicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistanceJ Infect Dis199817811591639652435
   PubMed Web of Science ®Google Scholar
• MurrayBEDiversity among multidrug-resistant enterococciEmerg Infect Dis19984137479452397
   PubMed Web of Science ®Google Scholar
• MurrayBEBeta-lactamase-producing enterococciAntimicrob Agents Chemother19923611235523591489177
   PubMed Web of Science ®Google Scholar
• HorodniceanuTBougueleretLEl-SolhNBiethGDelbosFHigh-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenesAntimicrob Agents Chemother1979165686689118707
   PubMed Web of Science ®Google Scholar
• Mederski-SamorajBDMurrayBEHigh-level resistance to gentamicin in clinical isolates of enterococciJ Infect Dis198314747517576404994
   PubMed Web of Science ®Google Scholar
• EliopoulosGMAminoglycoside resistant enterococcal endocarditisInfect Dis Clin North Am1993711171338463648
   PubMed Web of Science ®Google Scholar
• MainardiJLVilletRBuggTDMayerCArthurMEvolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteriaFEMS Microbiol Rev200832238640818266857
   PubMed Web of Science ®Google Scholar
• WalshCMolecular mechanisms that confer antibacterial drug resistanceNature2000406679777578110963607
   PubMed Web of Science ®Google Scholar
• CourvalinPVancomycin resistance in Gram-positive cocciClin Infect Dis200642Suppl 1S25S3416323116
   PubMed Web of Science ®Google Scholar
• BoydDAWilleyBMFawcettDGillaniNMulveyMRMolecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanLAntimicrob Agents Chemother20085272667267218458129
   PubMed Web of Science ®Google Scholar
• LebretonFDepardieuFBourdonND-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faeciumAntimicrob Agents Chemother201155104606461221807981
   PubMed Web of Science ®Google Scholar
• McKessarSJBerryAMBellJMTurnidgeJDPatonJCGenetic charac-terization of vanG, a novel vancomycin resistance locus of Enterococcus faecalisAntimicrob Agents Chemother200044113224322811036060
   PubMed Web of Science ®Google Scholar
• XuXLinDYanGvanM, a new glycopeptide resistance gene cluster found in Enterococcus faeciumAntimicrob Agents Chemother201054114643464720733041
   PubMed Web of Science ®Google Scholar
• FisherKPhillipsCThe ecology, epidemiology and virulence of EnterococcusMicrobiology2009155pt 61749175719383684
   PubMed Web of Science ®Google Scholar
• WernerGCoqueTMHammerumAMEmergence and spread of vancomycin resistance among enterococci in EuropeEuro Surveill200813471904619021959
   PubMedGoogle Scholar
• LindenPKOptimizing therapy for vancomycin-resistant enterococci (VRE)Semin Respir Crit Care Med200728663264518095227
   PubMed Web of Science ®Google Scholar
• CetinkayaYFalkPMayhallCGVancomycin-resistant enterococciClin Microbiol Rev200013468670711023964
   PubMed Web of Science ®Google Scholar
• BadenLRCritchleyIASahmDFMolecular characterization of vancomycin-resistant enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplaninJ Clin Microbiol20024041160116311923325
   PubMed Web of Science ®Google Scholar
• BontenMJHaydenMKNathanCRiceTWWeinsteinRAStability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patientsJ Infect Dis199817723783829466524
   PubMed Web of Science ®Google Scholar
• SnyderGMThomKAFurunoJPDetection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workersInfect Control Hosp Epidemiol200829758358918549314
   PubMed Web of Science ®Google Scholar
• NoskinGASiddiquiFStosorVKruzynskiJPetersonLRSuccessful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicinClin Infect Dis199928368969010194104
   PubMed Web of Science ®Google Scholar
• KramerASchwebkeIKampfGHow long do nosocomial pathogens persist on inanimate surfaces? A systematic reviewBMC Infect Dis2006613016914034
   PubMed Web of Science ®Google Scholar
• VergisENHaydenMKChowJWDeterminants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter studyAnn Intern Med2001135748449211578151
   PubMed Web of Science ®Google Scholar
• FurtadoGHMendesREPignatariACWeySBMedeirosEARisk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studiesAm J Infect Control200634744745116945692
   PubMed Web of Science ®Google Scholar
• ZacharioudakisIMZervouFNZiakasPDRiceLBMylonakisEVancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significanceAm J Kidney Dis2015651889725042816
   PubMed Web of Science ®Google Scholar
• Papadimitriou-OlivgerisMDrougkaEFligouFRisk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patientsInfection20144261013102225143193
   PubMed Web of Science ®Google Scholar
• Van der AuweraPPensartNKortenVMurrayBELeclercqRInfluence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococciJ Infect Dis19961735112911368627064
   PubMed Web of Science ®Google Scholar
• GhanemGHachemRJiangYChemalyRFRaadIOutcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patientsInfect Control Hosp Epidemiol20072891054105917932826
   PubMed Web of Science ®Google Scholar
• TornieporthNGRobertsRBJohnJHafnerARileyLWRisk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patientsClin Infect Dis19962347677728909842
   PubMed Web of Science ®Google Scholar
• FridkinSKEdwardsJRCourvalJMIntensive Care Antimicrobial Resistance Epidemiology (ICARE) ProjectThe National Nosocomial Infections Surveillance (NNIS) System HospitalsThe effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care unitsAnn Intern Med2001135317518311487484
   PubMed Web of Science ®Google Scholar
• HidronAIEdwardsJRPatelJNational Healthcare Safety Network TeamParticipating National Healthcare Safety Network FacilitiesNHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007Infect Control Hosp Epidemiol20082911996101118947320
   PubMed Web of Science ®Google Scholar
• ZhanelGGAdamHJBaxterMRCanadian Antimicrobial Resistance AllianceAntimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007–2011 studyJ Antimicrob Chemother201368Suppl 1i7i2223587781
   PubMed Web of Science ®Google Scholar
• GarrisonRNFryDEBerberichSPolkHCJrEnterococcal bacteremia: clinical implications and determinants of deathAnn Surg1982196143476807223
   PubMed Web of Science ®Google Scholar
• AriasCAMurrayBEEnterococcus species, Streptococcus gallolyticus group, and Leucomonstoc speciesBennettJEDolinRBlaserMJMandell, Douglas, and Bennett’s Principles and Practice of Infectious DiseasesPhiladelphiaSaunders201523282339
   Google Scholar
• DiazGranadosCAZimmerSMKleinMJerniganJAComparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysisClin Infect Dis200541332733316007529
   PubMed Web of Science ®Google Scholar
• SalgadoCDThe risk of developing a vancomycin-resistant Enterococ-cus bloodstream infection for colonized patientsAm J Infect Control20083610S175.e5e8.19084155
   PubMedGoogle Scholar
• HillEEHerijgersPClausPVanderschuerenSHerregodsMCPeetermansWEInfective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort studyEur Heart J200728219620317158121
   PubMed Web of Science ®Google Scholar
• ForrestGNArnoldRSGammieJSGilliamBLSingle center experience of a vancomycin resistant enterococcal endocarditis cohortJ Infect201163642042821920382
   PubMed Web of Science ®Google Scholar
• MurrayBEThe life and times of the EnterococcusClin Microbiol Rev19903146652404568
   PubMed Web of Science ®Google Scholar
• Fernandez GuerreroMLGoyenecheaAVerdejoCRoblasRFde GorgolasMEnterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcomeMedicine200786636337718004181
   PubMed Web of Science ®Google Scholar
• HarbarthSUckayIAre there patients with peritonitis who require empiric therapy for Enterococcus?Eur J Clin Microbiol Infect Dis2004232737714735401
   PubMed Web of Science ®Google Scholar
• GuptaKBhadeliaNManagement of urinary tract infections from multidrug-resistant organismsInfect Dis Clin North Am2014281495924484574
   PubMed Web of Science ®Google Scholar
• WangJSMuzevichKEdmondMBBearmanGStevensMPCentral nervous system infections due to vancomycin-resistant enterococci: case series and review of the literatureInt J Infect Dis201425263124846601
   PubMed Web of Science ®Google Scholar
• Agudelo HiguitaNIHuyckeMMEnterococcal disease, epidemiology, and implications for treatmentGilmoreMSClewellDBIkeYEnterococci: From Commensals to Leading Causes of Drug Resistant Infection [Internet]BostonMassachusetts Eye and Ear Infirmary2014127 Available from: http://www.ncbi.nlm.nih.gov/books/NBK190429/Accessed January 1, 2015
   Google Scholar
• WilliamsonJCCraftDWButtsJDRaaschRHIn vitro assessment of urinary isolates of ampicillin-resistant enterococciAnn Pharmacother200236224625011847942
   PubMed Web of Science ®Google Scholar
• WatanakunakornCPatelRComparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicinClin Infect Dis199317174788353250
   PubMed Web of Science ®Google Scholar
• KrogstadDJPargwetteARDefective killing of enterococci: a common property of antimicrobial agents acting on the cell wallAntimicrob Agents Chemother19801769659686902640
   PubMed Web of Science ®Google Scholar
• MurrayBEVancomycin-resistant enterococcal infectionsN Engl J Med20003421071072110706902
   PubMed Web of Science ®Google Scholar
• DodgeRADalyJSDavaroRGlewRHHigh-dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multiresistant enterococciClin Infect Dis1997255126912709402411
   PubMed Web of Science ®Google Scholar
• Fernández-HidalgoNAlmiranteBGavaldàJAmpicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditisClin Infect Dis20135691261126823392394
   PubMed Web of Science ®Google Scholar
• MainardiJLGutmannLAcarJFGoldsteinFWSynergistic effect of amoxicillin and cefotaxime against Enterococcus faecalisAntimicrob Agents Chemother1995399198419878540703
   PubMed Web of Science ®Google Scholar
• SinghKVWeinstockGMMurrayBEAn Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristinAntimicrob Agents Chemother20024661845185012019099
   PubMed Web of Science ®Google Scholar
• Synercid^® IV (quinupristin/dalfopristin) [package insert]New York, NYPfizer Inc2013
   Google Scholar
• LindenPKMoelleringRCWoodCASynercid Emergency-Use Study GroupTreatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristinClin Infect Dis200133111816182311668430
   PubMed Web of Science ®Google Scholar
• BaddourLMWilsonWRBayerASCommittee on Rheumatic Fever, Endocarditis, and Kawasaki DiseaseCouncil on Cardiovascular Disease in the YoungCouncils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and AnesthesiaAmerican Heart AssociationInfectious Diseases Society of AmericaInfective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of AmericaCirculation200511123e394e43415956145
   PubMed Web of Science ®Google Scholar
• BrownJFreemanBB3rdCombining quinupristin/dalfopristin with other agents for resistant infectionsAnn Pharmacother200438467768514990776
   PubMed Web of Science ®Google Scholar
• KnollBMHellmannMKottonCNVancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literatureScand J Infect Dis201345213113922992165
   PubMed Web of Science ®Google Scholar
• DeverLLSmithSMDejesusDTreatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen casesMicrob Drug Resist1996244074139158811
   PubMed Web of Science ®Google Scholar
• ScheetzMHKnechtelSAMalczynskiMPostelnickMJQiCIncreasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumptionAntimicrob Agents Chemother20085262256225918391028
   PubMed Web of Science ®Google Scholar
• DiazLKiratisinPMendesREPanessoDSinghKVAriasCATransferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalisAntimicrob Agents Chemother20125673917392222491691
   PubMed Web of Science ®Google Scholar
• BirminghamMCRaynerCRMeagherAKFlavinSMBattsDHSchentagJJLinezolid for the treatment of multidrug-resistant, Gram-positive infections: experience from a compassionate-use programClin Infect Dis200336215916812522747
   PubMed Web of Science ®Google Scholar
• TsigrelisCSinghKVCoutinhoTDMurrayBEBaddourLMVancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factorsJ Clin Microbiol200745263163517182759
   PubMed Web of Science ®Google Scholar
• BornerKBornerELodeHDetermination of linezolid in human serum and urine by high-performance liquid chromatographyInt J Antimicrob Agents200118325325811673038
   PubMed Web of Science ®Google Scholar
• HillDMWoodGCHickersonWLLinezolid bladder irrigation as adjunctive treatment for a vancomycin-resistant Enterococcus faecium catheter-associated urinary tract infectionAnn Pharmacother201549225025325515867
   PubMed Web of Science ®Google Scholar
• MyrianthefsPMarkantonisSLVlachosKSerum and cerebrospinal fluid concentrations of linezolid in neurosurgical patientsAntimicrob Agents Chemother200650123971397616982782
   PubMed Web of Science ®Google Scholar
• RybakJMMarxKMartinCAEarly experience with tedizolid: clinical efficacy, pharmacodynamics, and resistancePharmacotherapy201434111198120825266820
   PubMed Web of Science ®Google Scholar
• BrownSDTraczewskiMMComparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control rangesAntimicrob Agents Chemother20105452063206920231392
   PubMed Web of Science ®Google Scholar
• LockeJBFinnJHilgersMStructure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribo-somal mutationsAntimicrob Agents Chemother201054125337534320837751
   PubMed Web of Science ®Google Scholar
• BalliEPVenetisCAMiyakisSSystematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremiaAntimicrob Agents Chemother201458273473924247127
   PubMed Web of Science ®Google Scholar
• ChuangYCWangJTLinHYChangSCDaptomycin versus lin-ezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysisBMC Infect Dis201414168725495779
   PubMed Web of Science ®Google Scholar
• ReyesKZervosMEndocarditis caused by resistant Enterococcus: an overviewCurr Infect Dis Rep201315432032823749322
   PubMed Web of Science ®Google Scholar
• PfallerMASaderHSJonesRNEvaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002–2005)Diagn Microbiol Infect Dis200757445946517240105
   PubMed Web of Science ®Google Scholar
• WerthBJSteedMEIrelandCEDefining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalisAntimicrob Agents Chemother20145895253526124957825
   PubMed Web of Science ®Google Scholar
• MurrayKPZhaoJJDavisSLEarly use of daptomycin versus van-comycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration .1 mg/L: a matched cohort studyClin Infect Dis201356111562156923449272
   PubMed Web of Science ®Google Scholar
• CasapaoAMKullarRDavisSLMulticenter study of high-dose daptomycin for treatment of enterococcal infectionsAntimicrob Agents Chemother20135794190419623774437
   PubMed Web of Science ®Google Scholar
• MuellerSWKiserTHAndersonTANeumannRTIntraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin- resistant Enterococcus faeciumAnn Pharmacother20124612e3523232018
   PubMedGoogle Scholar
• HassounAACoomerRWMendez-VigoLIntraperitoneal dapto-mycin used to successfully treat vancomycin-resistant Enterococcus peritonitisPerit Dial Int200929667167319910570
   PubMed Web of Science ®Google Scholar
• FisherLNorthDEffectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infectionsInt J Antimicrob Agents200933549349419153034
   PubMed Web of Science ®Google Scholar
• WerthBJBarberKETranKNCeftobiprole and ampicil-lin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VREJ Antimicrob Chemother201570248949325304643
   PubMed Web of Science ®Google Scholar
• SakoulasGRoseWNonejuiePCeftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Entero-coccus faeciumAntimicrob Agents Chemother20145831494150024366742
   PubMed Web of Science ®Google Scholar
• EntenzaJMGiddeyMVouillamozJMoreillonPIn vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillinInt J Antimicrob Agents201035545145620185277
   PubMed Web of Science ®Google Scholar
• Hall SnyderAWerthBJBarberKESakoulasGRybakMJEvaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation modelJ Antimicrob Chemother20146982148215424777900
   PubMed Web of Science ®Google Scholar
• SakoulasGBayerASPoglianoJAmpicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faeciumAntimicrob Agents Chemother201256283884422123698
   PubMed Web of Science ®Google Scholar
• DiazLTranTTMunitaJMWhole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICsAntimicrob Agents Chemother20145884527453424867964
   PubMed Web of Science ®Google Scholar
• MeagherAKAmbrosePGGraselaTHEllis-GrosseEJThe phar-macokinetic and pharmacodynamic profile of tigecyclineClin Infect Dis200541Suppl 5S333S34016080071
   PubMed Web of Science ®Google Scholar
• CurcioDTreatment of recurrent urosepsis with tigecycline: a pharmacological perspectiveJ Clin Microbiol20084651892189318460636
   PubMed Web of Science ®Google Scholar
• JenkinsILinezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycinJ Hosp Med20072534334417935250
   PubMed Web of Science ®Google Scholar
• ScheetzMHReddyPNicolauDPPeritoneal fluid penetration of tigecyclineAnn Pharmacother200640112064206717047138
   PubMed Web of Science ®Google Scholar
• ZhanelGGCalicDSchweizerFNew lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancinDrugs201070785988620426497
   PubMed Web of Science ®Google Scholar
• Dalvance^® (dalbavancin) [package insert]Chicago, ILDurata Therapeutics, Inc2014
   Google Scholar
• VIBATIV^® (telavancin) [package insert]Deerfield, ILAstellas Pharma US2009
   Google Scholar
• BaltchALSmithRPRitzWJBoppLHComparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faeciumAntimicrob Agents Chemother19984210256425689756756
   PubMed Web of Science ®Google Scholar
• LefortASaleh-MghirAGarryLCarbonCFantinBActivity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalisAntimicrob Agents Chemother200044113017302111036016
   PubMed Web of Science ®Google Scholar
• ZhanelGGHobanDJKarlowskyJANitrofurantoin is active against vancomycin-resistant enterococciAntimicrob Agents Chemother200145132432611120989
   PubMed Web of Science ®Google Scholar
• ShresthaNKChuaJDTuohyMJAntimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycinScand J Infect Dis2003351121412685877
   PubMed Web of Science ®Google Scholar
• LautenbachESchusterMGBilkerWBBrennanPJThe role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant EnterococcusClin Infect Dis1998275125912659827280
   PubMed Web of Science ®Google Scholar
• RosenthalVDMakiDGMehtaYInternational Nosocomial Infection Control ConsortiumInternational Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007–2012. Device-associated moduleAm J Infect Control201442994295625179325
   PubMed Web of Science ®Google Scholar
• Zyvox^® (linezolid) [package insert]New York, NYPfizer Inc2007
   Google Scholar
• Cubicin^® (daptomycin) [package insert]Lexington, MACubist Pharmaceuticals2010
   Google Scholar
• Tygacil^® (tigecycline) [package insert]Philadelphia, PAWyeth Pharmaceuticals2011
   Google Scholar
• Sivextro^® (tedizolid phosphate) [package insert]Lexington, MACubist Pharmaceuticals2014
   Google Scholar
• Orbactiv^® (oritavancin) [package insert]Parsippany, NJThe Medicines Company2014
   Google Scholar